Comment

Comment by smiley1437

Tirzepatide (and likely other GLPs) have limitations that are rarely brought up in the general media

- Patients have about 72 weeks to reach maximum loss, they don't lose any more weight after 72 weeks even on the highest dose.

- Patients appear to immediately gain the weight back as soon as they stop taking it.

It's right in the phase 3 trial outcomes paper:

https://pmc.ncbi.nlm.nih.gov/articles/PMC10667099/

I suspect that this info is intentionally down-played so that it doesn't affect sales.

parent smiley1437 1 year ago

Discussion

Live from the official Hacker News API

A modern reader for Hacker News · SvelteKit + Skeleton